NAP1L1 Human

Nucleosome Assembly Protein 1-Like 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Functional Roles

NAP1L1 serves as a histone chaperone with diverse roles:

  • Chromatin Assembly: Facilitates nucleosome formation by shuttling histones H2A-H2B into the nucleus .

  • DNA Repair: Enhances ERCC6-mediated transcription-coupled repair and RAD51/RAD54-dependent homologous recombination .

  • Cell Cycle Regulation: Promotes G2/M phase transition via CDK1 and β-catenin activation .

  • Disease Pathways:

    • Cancer: Drives hepatocellular carcinoma (HCC) progression through Wnt/β-catenin signaling and immune modulation .

    • Cardiac Fibrosis: Binds YAP1 to stabilize its expression, promoting fibroblast proliferation and differentiation .

3.1. Cancer Biomarker

  • Prognostic Value: High NAP1L1 expression correlates with poor survival in HCC (HR = 1.67, p < 0.001) and colorectal cancer .

  • Mechanistic Insights:

    • Silencing NAP1L1 reduces β-catenin and CDK1 levels, arresting HCC cells in G2/M phase .

    • Interacts with UBR4 to regulate BIRC2 ubiquitination, influencing apoptosis resistance .

Cancer TypeKey FindingsReference
Hepatocellular CarcinomaUpregulated in tumors; linked to macrophage infiltration and Wnt pathway activation
Colorectal CancerElevated mRNA levels in tumor tissues; nuclear expression predicts survival

3.2. Non-Oncological Roles

  • Platelet Function: Binds DLAT (PDC-E2) to modulate mitochondrial PDH activity, impacting thrombopoiesis .

  • Neurogenesis: Regulates neural progenitor proliferation via RASSF10 promoter methylation .

Research Applications

NAP1L1 is widely used in:

  • Chromatin Assembly Assays: Validated for histone deposition and nucleosome remodeling .

  • Protein Interaction Studies: Identified partners include HDGF, c-Jun, and YAP1 .

  • Disease Modeling:

    • In vitro HCC studies demonstrate its role in chemotherapy resistance .

    • Cardiac fibrosis models link NAP1L1 to YAP1 stability and fibroblast activation .

Key Research Findings

Study FocusModelMajor OutcomeReference
HCC ProgressionTCGA, ICGC datasetsNAP1L1 activates Wnt/β-catenin and G2/M transition
Apoptosis RegulationHCC cell linesNAP1L1 knockdown increases apoptosis via BIRC2 ubiquitination
Cardiac FibrosisMouse MI modelNAP1L1 knockout reduces fibrosis and improves heart function
Platelet BiogenesisHuman MKs/PLTsNAP1L1 modulates PDH activity and proplatelet formation

Future Directions

Current research gaps include:

  • Mechanistic Depth: How NAP1L1 precisely regulates immune cells (e.g., macrophages) in HCC.

  • Therapeutic Targeting: Small-molecule inhibitors to disrupt NAP1L1-YAP1 or NAP1L1-UBR4 interactions.

  • Clinical Validation: Multicenter studies to confirm its prognostic utility across cancer types.

Product Specs

Introduction
NAP1L1, a member of the nucleosome assembly protein family, participates in DNA replication, chromatin formation modulation, and cell proliferation regulation.
Description
Recombinant human NAP1L1, produced in E. coli, is a non-glycosylated polypeptide chain (408 amino acids, 1-388 a.a.) with a molecular weight of 47.2 kDa. It includes a 20 amino acid His-tag at the N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The NAP1L1 protein solution (1 mg/ml) is supplied in a buffer containing 20 mM Tris-HCl (pH 8.0), 1 mM DTT, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 90% as determined by SDS-PAGE analysis.
Synonyms
Nucleosome assembly protein 1-like 1, NRP, hNRP, NAP1L, NAP1, NAP-1-related protein, HSP22-like protein interacting protein, MGC23410, MGC8688.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MADIDNKEQS ELDQDLDDVE EVEEEETGEE TKLKARQLTV QMMQNPQILA ALQERLDGLV ETPTGYIESL PRVVKRRVNA LKNLQVKCAQ IEAKFYEEVH DLERKYAVLY QPLFDKRFEI INAIYEPTEE ECEWKPDEED EISEELKEKA KIEDEKKDEE KEDPKGIPEF WLTVFKNVDL LSDMVQEHDE PILKHLKDIK VKFSDAGQPM SFVLEFHFEP NEYFTNEVLT KTYRMRSEPD DSDPFSFDGP EIMGCTGCQI DWKKGKNVTL KTIKKKQKHK GRGTVRTVTK TVSNDSFFNF FAPPEVPESG DLDDDAEAIL AADFEIGHFL RERIIPRSVL YFTGEAIEDD DDDYDEEGEE ADEEGEEEGD EENDPDYDPK KDQNPAEC.

Q&A

Experimental Design for Studying NAP1L1 Function

Q: How can I design experiments to study the role of NAP1L1 in nucleosome assembly and DNA repair mechanisms? A: To study NAP1L1's role, you can use a combination of biochemical assays and cell-based experiments. For example, co-immunoprecipitation can help identify interactions with histones and other DNA repair proteins. Additionally, using siRNA or CRISPR to knockdown NAP1L1 in cells can reveal its impact on nucleosome assembly and DNA repair processes like homologous recombination and nucleotide excision repair .

Data Analysis for Contradictory Results

Q: How do I analyze contradictory data regarding NAP1L1's involvement in different cellular processes? A: When analyzing contradictory data, consider the experimental conditions, cell types used, and the specific assays performed. For instance, differences in NAP1L1's role in DNA repair versus neurogenesis might stem from variations in cellular context or experimental design. Use meta-analysis techniques to synthesize findings across studies and identify potential biases or confounding factors .

Advanced Research Questions on NAP1L1's Mechanism

Q: What advanced techniques can I use to investigate the molecular mechanisms by which NAP1L1 influences nucleosome remodeling and chromatin dynamics? A: Techniques such as single-molecule fluorescence microscopy and chromatin immunoprecipitation sequencing (ChIP-seq) can provide insights into NAP1L1's role in nucleosome remodeling and chromatin structure. These methods allow for the observation of real-time interactions between NAP1L1 and chromatin components at high resolution .

Methodological Considerations for NAP1L1 Expression Studies

Q: How can I ensure accurate measurement of NAP1L1 expression levels in different tissues or cell types? A: For accurate measurement of NAP1L1 expression, use quantitative real-time PCR (qRT-PCR) with validated primers and normalize against appropriate housekeeping genes. Additionally, consider using Western blotting to confirm protein levels, as mRNA levels may not always correlate with protein expression due to post-transcriptional regulation .

NAP1L1 in Disease Models

Q: What approaches can be used to study NAP1L1's potential role in disease models, such as cancer or neurodevelopmental disorders? A: To study NAP1L1's role in disease models, use genetically modified animal models or cell lines where NAP1L1 expression is altered. Analyze phenotypic changes and molecular alterations in these models using techniques like RNA sequencing and ChIP-seq to understand how NAP1L1 contributes to disease pathology .

Interpretation of NAP1L1's Role in Neurogenesis

Q: How can I interpret the role of NAP1L1 in regulating neurogenesis, particularly its impact on neural progenitor proliferation and differentiation? A: Interpretation of NAP1L1's role in neurogenesis involves analyzing its effects on neural progenitor cell proliferation and differentiation markers. Use techniques like immunofluorescence staining for neural markers and BrdU incorporation assays to assess cell proliferation. Additionally, examine the expression of genes involved in neurogenesis pathways to understand how NAP1L1 modulates these processes .

NAP1L1 and Chromatin Remodeling

Q: What methods can be employed to study how NAP1L1 interacts with chromatin remodeling complexes and influences nucleosome dynamics? A: To study NAP1L1's interaction with chromatin remodeling complexes, use biochemical assays such as co-immunoprecipitation and in vitro nucleosome remodeling assays. Techniques like single-molecule FRET can provide real-time insights into how NAP1L1 affects nucleosome movement and stability .

NAP1L1 as a Biomarker

Q: How can NAP1L1 be evaluated as a potential biomarker for diseases like colorectal cancer? A: To evaluate NAP1L1 as a biomarker, conduct studies comparing its expression levels in diseased versus healthy tissues using techniques like qRT-PCR and Western blotting. Analyze the correlation between NAP1L1 expression and disease progression or prognosis. Additionally, consider using liquid biopsy techniques to assess NAP1L1 levels in circulating biomarkers .

Advanced Techniques for Studying NAP1L1 Interactions

Q: What advanced biophysical techniques can be used to study the interactions between NAP1L1 and histones or other chromatin-associated proteins? A: Techniques such as surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), and nuclear magnetic resonance (NMR) spectroscopy can provide detailed insights into the binding affinities and structural interactions between NAP1L1 and its protein partners .

Data Integration and Bioinformatics Analysis

Q: How can I integrate and analyze large-scale genomic and proteomic data related to NAP1L1 to identify novel regulatory pathways? A: Use bioinformatics tools like pathway analysis software (e.g., Metascape) to integrate genomic and proteomic data. Perform gene set enrichment analysis (GSEA) to identify pathways enriched with NAP1L1-interacting genes. Additionally, construct regulatory networks using tools like Cytoscape to visualize interactions between NAP1L1 and other proteins or genes .

Table: NAP1L1 Protein Characteristics

CharacteristicDescription
SourceExpressed in Escherichia coli
Purity>90%
Length1-388 amino acids (full-length)
Molecular MassApproximately 47.2 kDa
FunctionHistone chaperone involved in nucleosome assembly and DNA repair

Figure: NAP1L1's Role in Nucleosome Remodeling

To visualize NAP1L1's role in nucleosome remodeling, consider using diagrams that illustrate how it interacts with chromatin remodeling complexes and histones to facilitate nucleosome assembly and disassembly. This can help in understanding its impact on chromatin dynamics and gene expression.

Product Science Overview

Gene and Protein Structure

The NAP1L1 gene is located on chromosome 12 in humans and encodes a protein that is highly conserved across different species . The protein consists of several domains that facilitate its interaction with histones and other chromatin-associated proteins. These domains include:

  • N-terminal domain: Involved in binding to histones H2A-H2B.
  • C-terminal acidic domain: Plays a role in chromatin remodeling and nucleosome assembly.
  • Earmuff domain: Important for the interaction with histones and other proteins involved in chromatin dynamics .
Biological Functions

NAP1L1 functions primarily as a histone chaperone, facilitating the proper assembly and disassembly of nucleosomes. This activity is essential for maintaining chromatin structure and regulating gene expression. Some of the key functions of NAP1L1 include:

  • Nucleosome Assembly: NAP1L1 assists in the deposition of histones H2A and H2B onto DNA, forming nucleosomes .
  • DNA Repair: It enhances chromatin remodeling, which is crucial for DNA repair mechanisms such as transcription-coupled nucleotide excision repair and homologous recombination .
  • Cell Proliferation: NAP1L1 is involved in modulating chromatin formation, thereby contributing to the regulation of cell proliferation .
Expression Patterns and Tissue Distribution

NAP1L1 is ubiquitously expressed in various tissues, with higher expression levels observed in rapidly proliferating cells. Its expression is tightly regulated during the cell cycle, ensuring proper chromatin dynamics during DNA replication and cell division .

Regulatory Mechanisms

The activity of NAP1L1 is regulated through various post-translational modifications, including phosphorylation and acetylation. These modifications influence its interaction with histones and other chromatin-associated proteins, thereby modulating its function in nucleosome assembly and chromatin remodeling .

Clinical Significance

Mutations or dysregulation of NAP1L1 have been associated with several diseases, including certain cancers and viral infections. For instance, NAP1L1 has been implicated in the reactivation of Epstein-Barr virus in epithelial cells . Additionally, its role in cell proliferation and DNA repair makes it a potential target for therapeutic interventions in cancer treatment .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.